{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:55:23Z","timestamp":1791244523131,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-60922-y","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T12:34:35Z","timestamp":1783341275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors associated with non-steroidal anti-inflammatory drug continuation at discharge in patients with heart failure"],"prefix":"10.1038","volume":"16","author":[{"given":"Tomiko","family":"Sunaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiru","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Iso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mio","family":"Ebato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"60922_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/ejhf.3642","volume":"27","author":"D Stolfo","year":"2025","unstructured":"Stolfo, D. et al. How to handle polypharmacy in heart failure: A clinical consensus statement of the Heart Failure Association of the ESC. Eur. J. Heart Fail. 27, 747\u2013759 (2025).","journal-title":"Eur. J. Heart Fail."},{"key":"60922_CR2","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/ggi.13773","volume":"19","author":"T Kimura","year":"2019","unstructured":"Kimura, T. et al. Efficacy of pharmacists\u2019 assessment and intervention based on STOPP-J compared with STOPP criteria version 2 in older patients with cardiovascular disease. Geriatr. Gerontol. Int. 19, 1101\u20131107 (2019).","journal-title":"Geriatr. Gerontol. Int."},{"key":"60922_CR3","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1016\/j.sapharm.2021.06.023","volume":"18","author":"C Hern\u00e1ndez-Prats","year":"2022","unstructured":"Hern\u00e1ndez-Prats, C., L\u00f3pez-Pintor, E. & Lumbreras, B. Pharmacist-led intervention on the reduction of inappropriate medication use in patients with heart failure: A systematic review of randomized trials and non-randomized intervention studies. Res. Social Adm. Pharm. 18, 2748\u20132756 (2022).","journal-title":"Res. Social Adm. Pharm."},{"key":"60922_CR4","first-page":"498","volume":"19","author":"J Duangsong","year":"2022","unstructured":"Duangsong, J., Samansaplert, P., Khamkong, Y. & Jenghua, K. Use of potentially inappropriate medications for heart failure according to the three sets of heart failure-specific criteria in Thai older patients with heart failure. J. Geriatr. Cardiol. 19, 498\u2013510 (2022).","journal-title":"J. Geriatr. Cardiol."},{"key":"60922_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jchf.2019.08.007","volume":"8","author":"P Goyal","year":"2020","unstructured":"Goyal, P. et al. Prescribing patterns of heart failure-exacerbating medications following a heart failure hospitalization. JACC Heart Fail. 8, 25\u201334 (2020).","journal-title":"JACC Heart Fail."},{"key":"60922_CR6","unstructured":"Ministry of Health, Labour and Welfare. Survey report on the working conditions of hospital pharmacists (2022). https:\/\/www.mhlw.go.jp\/content\/11121000\/001322143.pdf."},{"key":"60922_CR7","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.chest.2024.04.012","volume":"166","author":"HB Gershengorn","year":"2024","unstructured":"Gershengorn, H. B. et al. ICU staffing in the United States. Chest 166, 743\u2013753 (2024).","journal-title":"Chest"},{"key":"60922_CR8","doi-asserted-by":"crossref","unstructured":"Position paper on critical care pharmacists in Japan. J. Jpn. Soc. Intensive Care Med. 27, 244\u2013247. https:\/\/www.jsicm.org\/publication\/pdf\/pp_cc_pharmacists.pdf (2020).","DOI":"10.3918\/jsicm.27_244"},{"key":"60922_CR9","doi-asserted-by":"publisher","first-page":"e8525","DOI":"10.1136\/bmj.e8525","volume":"346","author":"F Lapi","year":"2013","unstructured":"Lapi, F., Azoulay, L., Yin, H., Nessim, S. J. & Suissa, S. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: Nested case-control study. BMJ 346, e8525 (2013).","journal-title":"BMJ"},{"key":"60922_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s40780-025-00485-8","volume":"11","author":"Y Kunitsu","year":"2025","unstructured":"Kunitsu, Y. et al. NSAID-induced acute kidney injury risk in patients on renin-angiotensin system inhibitors and diuretics: nationwide cohort study. J. Pharm. Health Care Sci. 11, 77 (2025).","journal-title":"J. Pharm. Health Care Sci."},{"key":"60922_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.14740\/cr1078","volume":"11","author":"T Sunaga","year":"2020","unstructured":"Sunaga, T. et al. Association of potentially inappropriate medications with all-cause mortality in the elderly acute decompensated heart failure patients: Importance of non-steroidal anti-inflammatory drug prescription. Cardiol. Res. 11, 239\u2013246 (2020).","journal-title":"Cardiol. Res."},{"key":"60922_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1124\/jpet.122.001413","volume":"386","author":"O Parish","year":"2023","unstructured":"Parish, O. et al. Prognostic role of contraindicated drugs in hospitalized patients with decompensated heart failure. J. Pharmacol. Exp. Ther. 386, 205\u2013211 (2023).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"60922_CR13","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s11096-020-01088-z","volume":"42","author":"S Imai","year":"2020","unstructured":"Imai, S. et al. A cross-sectional exploratory survey on occurrence of triple-whammy prescription pattern in Japan. Int. J. Clin. Pharm. 42, 1369\u20131373 (2020).","journal-title":"Int. J. Clin. Pharm."},{"key":"60922_CR14","unstructured":"Ministry of Health, Labour and Welfare. Survey on the working conditions of hospital pharmacists 2022: reports. https:\/\/www.mhlw.go.jp\/content\/001298158.pdf"},{"key":"60922_CR15","doi-asserted-by":"publisher","first-page":"2594821","DOI":"10.1080\/20523211.2025.2594821","volume":"18","author":"T Sunaga","year":"2025","unstructured":"Sunaga, T. et al. Potentially inappropriate medications for patients with heart failure: A nationwide retrospective study from 2012 to 2022. J. Pharm. Policy Pract. 18, 2594821 (2025).","journal-title":"J. Pharm. Policy Pract."},{"key":"60922_CR16","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1002\/bcp.70263","volume":"91","author":"DM Calvo","year":"2025","unstructured":"Calvo, D. M., Saiz, L. C., Leache, L., Celaya, M. C. & Guti\u00e9rrez-Valencia, M. Acute kidney injury and morbi-mortality associated with \u201ctriple whammy\u201d combination: Systematic review and meta-analysis. Br. J. Clin. Pharmacol. 91, 3031\u20133041 (2025).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"60922_CR17","doi-asserted-by":"publisher","first-page":"BJGPO.2021.0208","DOI":"10.3399\/BJGPO.2021.0208","volume":"6","author":"SX Lin","year":"2022","unstructured":"Lin, S. X. et al. Characterising risk of non-steroidal anti-inflammatory drug-related acute kidney injury: A retrospective cohort study. BJGP Open 6, BJGPO.2021.0208 (2022).","journal-title":"BJGP Open"},{"key":"60922_CR18","unstructured":"Japan College of Rheumatology. Guidelines for the management of rheumatoid arthritis 2024. https:\/\/minds.jcqhc.or.jp\/common\/wp-content\/plugins\/pdfjs-viewer-shortcode\/pdfjs\/web\/viewer.php?file=https:\/\/minds.jcqhc.or.jp\/common\/summary\/pdf\/c00843.pdf&dButton=false&pButton=false&oButton=false&sButton=true#zoom=auto&pagemode=none&_wpnonce=3b871a512b."},{"key":"60922_CR19","doi-asserted-by":"publisher","first-page":"e503","DOI":"10.5435\/JAAOS-D-23-00806","volume":"32","author":"N Peterman","year":"2024","unstructured":"Peterman, N. et al. National trends in orthopaedic pain management from 2016 to 2020. J. Am. Acad. Orthop. Surg. 32, e503\u2013e513 (2024).","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"60922_CR20","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1513\/AnnalsATS.201303-040OC","volume":"10","author":"MH Roberts","year":"2013","unstructured":"Roberts, M. H., Mapel, D. W., Hartry, A., Von Worley, A. & Thomson, H. Chronic pain and pain medication use in chronic obstructive pulmonary disease: A cross-sectional study. Ann. Am. Thorac. Soc. 10, 290\u2013298 (2013).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"60922_CR21","unstructured":"Pharmacologic management of COPD: an official ATS clinical practice guideline (2020). https:\/\/www.thoracic.org\/statements\/guideline-implementation-tools\/pharmacologic-mgmt-of-copd.php."},{"key":"60922_CR22","unstructured":"The Japanese Respiratory Society. The JRS guideline for the management of chronic obstructive pulmonary disease 2022. https:\/\/www.jrs.or.jp\/publication\/file\/COPD6_20220726.pdf."},{"key":"60922_CR23","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 105, S117\u2013S314 (2024).","journal-title":"Kidney Int."},{"key":"60922_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/ajag.13380","volume":"44","author":"ECY Lau","year":"2025","unstructured":"Lau, E. C. Y., Jeon, Y. H., Hilmer, S. N. & Tan, E. C. K. Prescribing patterns in people living with dementia in the community: a cross-sectional study. Australas. J. Ageing 44, e13380 (2025).","journal-title":"Australas. J. Ageing"},{"key":"60922_CR25","doi-asserted-by":"crossref","unstructured":"Otsuka, H., Kawakami, Y., Shinozaki, M., Kawabata, H. & Yamanaka, T. Evaluation of oral medications in the geriatric medical care ward based on the Guidelines for Appropriate Use of Medications for the Elderly (2018), and an analysis of the number of oral medicines in relation to the nutritional route and activities of daily living (ADL) categories. Nihon Ronen Igakkai Zasshi 60, 382\u2013389 (2023)","DOI":"10.3143\/geriatrics.60.382"},{"key":"60922_CR26","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1253\/circj.CJ-20-0655","volume":"85","author":"T Matoba","year":"2021","unstructured":"Matoba, T. et al. Institutional characteristics and prognosis of acute myocardial infarction with cardiogenic shock in Japan- analysis from the JROAD\/JROAD-DPC database. Circ. J. 85, 1797\u20131805 (2021).","journal-title":"Circ. J."},{"key":"60922_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.36628\/ijhf.2023.0022","volume":"6","author":"E Zavaleta-Monestel","year":"2024","unstructured":"Zavaleta-Monestel, E. et al. Optimizing heart failure management: A review of clinical pharmacist integration. Int. J. Heart Fail. 6, 1\u201310 (2024).","journal-title":"Int. J. Heart Fail."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60922-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60922-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60922-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:17:52Z","timestamp":1791242272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60922-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60922"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60922-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used fully anonymized data from the JROAD\u2011DPC database, which is unlinked to identifiable medical records and does not contain personal or clinical identifiers such as vital signs or laboratory results. In accordance with Japanese ethical guidelines for medical and health research involving human subjects, the use of anonymized secondary data did not require individual informed consent. The study protocol was reviewed and approved by the relevant institutional ethics committee.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"31004"}}